{"summary": "infectious bronchitis (IB) causes significant economic losses to poultry industry. commercial losses are mainly due to decreased weight gain and egg production. some nephropathogenic IBV strains also affect the renal system and cause nephritis. self-assembling protein nanoparticles (SAPNs) are a novel vaccine platform. they are capable of self-assembling into structures that mimic the size and shape of small viruses. they can repetitively display epitopes on their surface when genetically fused to either the N- or C-terminus of the protein chain. the spike protein plays an essential role in attachment, virus-cell membrane fusion and host specificity during IBV infection. it consists of the two subunits S1 and S2 which are in the outer membrane and anchored in the viral membrane. the S2 subunit is hypervariable whereas the S2 subunit is relatively conserved [28] all animals were acclimated for one week prior to any experimental procedures. chickens had ad libitum access to water and feed, and were monitored daily by attending veterinarians during the study. all animals were supervised daily by the attending veterinarians providing care to reduce pain and stress. purification Expression was induced by adding 1 mM isopropyl -D-thiogalactopyranoside. pellets were re-suspended in lysis buffer 8M urea, 100 mM NaH2PO4, 20mM Tris base, pH 8.0. a 500 mM imidazole gradient was used to elute protein from the column. a molar ratio of 58:2 IBV-SAPN monomer to Flagellin-SAPN monomer was established based on protein concentration. chickens were given 200L vaccine formulation containing 100 g IBV-Flagellin-SAPN intramuscular injection. each animal received three doses at nine day intervals. chickens were bled once before vaccination and bled three times nine days after each immunization. PBMCs were stimulated in triplicate wells with 10 g/mL concanavalin A, 10 g/mL protein nanoparticle constructs, or 10 g/mL UV-inactivated IBV M41 strain. plates were incubated at 41\u00b0 C with 5% CO2 for 48 hours. the reaction was stopped by adding 25 L of 1M sulfuric acid to each well. the plates were washed and then incubated in the plates at room temperature for 1 hour. the eggs were incubated at 37\u00b0C for five days. the eggs were observed daily for embryo mortality. all eggs were kept at 4\u00b0C on the fifth day post-inoculation. histopathology Tracheal tissues were harvested after euthanasia and necropsy four days post challenge. a scoring scale was established with modification of previously described scoring method [35]. the second monomer contained the D0 and D1 domains (residues 4\u2013186 and 192\u2013282) of flagellin from Salmonella enterica serovar Typhimurium. to render the nanoparticle more immunogenic, the two CD4+ epitopes AKFVAAWTLKAAA and HAAHAAHAA were engineered into the scaffold of the SAPN. 100 mM NaH2PO4, 20 mM imidazole, 20mM Tris base, pH 8.0 were used to equilibrate hisTrap HP column. lysate was loaded into the equilibrated column and underwent washing with 5 volumes of binding buffer. columns were then washed with 5 column volumes of pH gradient phosphate buffer. SAPNs were absorbed on a carbon coated grid, stained with 0.5% uranyl acetate, and imaged using a FEI Tecnai 12 G2 Spirit BioTWIN. each animal received three doses at nine day intervals (at days 1, 11 and 21 of the experiment) each animal received three doses at nine days after each immunization. swabs were placed in brain heart infusion broth media, stored at -80 \u00b0C until tested. any chicken showing lacking of interest in food and water, difficulty in breathing, or depression were brought to the attention of the animal care office. plates were centrifuged at 300g for 10 min. labeling medium was removed thoroughly by flicking and tapping. one-hundred L/well FixDenat working solution was added to the microplates. secondary antibody (mouse anti-chicken Ig-Y, Southern Biotech, AL, USA) was added and incubated in the plates at a 1/1000 dilution at room temperature for 1 hour. plates were washed and then 50 L ELISA TMB substrate was applied to the wells at room temperature for 5 to 15 minutes. the reaction mix was prepared with 10 L master mix (SYBR green PCR master mix, Applied Biosystems), 0.25 L of 25 pmole forward and reverse primers. 4 L of cDNA template and nuclease-free water was added to bring the volume to 20 L. Dynamic light scattering showed a hydrodynamic diameter of 22.8 nm and 20 nm of IBV-Flagellin-SAPN and Flagellin-SAPN respectively. results show markedly elevated antibody responses in chickens vaccinated with IBV-Flagellin-SAPN. flagellin-SAPN and buffer control group had no detectable antibody response. vivo recall responses of PBMCs from chickens vaccinated with IBV-Flagellin-SAPN were significant. stimulation of PBMCs from chickens immunized with IBV-Flagellin-SAPN resulted in a significantly higher proliferation than that of the corresponding PBMC from the negative control group (Flagellin-SAPN) tracheal swab samples were used to extract RNA that was quantified by real time RT-PCR. chickens vaccinated with the IBV-Flagellin-SAPN had significantly lesser lesion scores in tracheal tissue than control groups. group had significantly lesser tracheal lesion scores than the flagellin-SAPN group or the buffer control group. results were consistent with the virus shedding in the trachea recorded at four days after challenge. IBV-Flagellin-SAPN and Flagellin-SAPN showed high purity and expected molecular weights of 37.8 kDa and 64.5 kDa. Dynamic light scattering showed a hydrodynamic diameter of 22.8 nm and 20 nm of IBV-Flagellin-SAPN and Flagellin-SAPN respectively. a reduction of shedding of IBV was detected in tracheas of chickens vaccinated with IBV-Flagellin-SAPN. PBMCs were pulsed with the respective SAPN at a final concentration of 10 g/mL. a significant reduction of virus induced by Flagellin-SAPN was found at two days post challenge. we quantified the RNA copy number of the recovered virus by real time RT-PCR. chickens vaccinated with IBV-Flagellin-SAPN had significantly lesser lesion scores. the IBV-Flagellin-SAPN group had significantly lesser tracheal lesion scores than the Flagellin-SAPN group or the buffer control group. these results were consistent with the virus shedding in the trachea recorded at four days after challenge. live attenuated vaccines are still the predominant vaccines in use. cytotoxicity of some nanoparticles is a major problem. cytotoxicity of some nanoparticles like titanium oxide, gold, or cationic lipids is a major problem. in the present study, we have developed a SAPN based IBV vaccine candidate. the malaria epitope CelTOS was included in the design because it renders the SAPNs biophysically well-behaved. this otherwise unrelated malaria protein included in the design of the IB vaccines is beneficial. coronavirus S2 protein is an -helical trimeric coiled-coil [58] therefore, a vaccine that displays HR in its native trimeric coiled-coil conformation would perform well in chickens. a SAPN that repetitively displays a SARS coronavirus B-cell epitope from the C-terminal HR of the virus\u2019 spike protein was able to neutralize SARS-coronavirus infectivity. IBV-Flagellin-SAPN vaccine has shown a clear potential to protect chickens against challenge with IBV M41 without co-administration of commercial adjuvants. this study incorporated flagellin to the SAPN as an immunostimulatory molecule to generate a self-adjuvanted SAPN. flagellin-SAPN had significantly lesser lesion scores in tracheal tissues. the protective effect may be attributed to the non-specific activation of natural killer cells and macrophages. the level of protection with the IBV-Flagellin-SAPN vaccine was significantly higher than that of Flagellin-SAPN based on both parameters. 1- IBV-SAPN monomer (Monomer A, Mw 37.8 kDa); 2- IBV-Flagellin-SAPN assembled from Monomer A and Monomer B at a 58:2 molar ratio. 3- Flagellin-SAPN monomer (Monomer B, Mw 64.5 kDa)."}